Evaluation of a reduced nicotine product standard: Moderating effects of and impact on cannabis use.

ABSTRACT:

Introduction

The Family Smoking Prevention and Tobacco Control Act authorized the FDA to reduce the nicotine content in cigarettes. Research is needed to guide proposed regulations, including evaluation of consequences to public health. This study evaluated how a reduced nicotine product standard might be moderated by and impact cannabis use.

Methods

Secondary analysis of a controlled clinical trial examining the effects of nicotine content in cigarettes in adult daily smokers. Linear regression assessed whether baseline cannabis use moderated behavioral, subjective, or physiological effects of smoking very low nicotine content (VLNC) versus normal nicotine content (NNC) cigarettes. Repeated measures analysis of associations between nicotine condition and prevalence and freq

SUBMITTER: Pacek LR 

PROVIDER: S-EPMC5037041 | biostudies-literature | 2016 Oct

REPOSITORIES: biostudies-literature